ACM Biosciences AG

ACM Biosciences AG was established in Basel, Switzerland in September 2020. It is dedicated to the development of infectious disease vaccines using it's proprietary ACM polymersome platform technology. Its current primary focus is to get a safe, effective and highly manufacturable COVID-19 vaccine t... Read more